The main purpose herein is to provide an up-to-date review on noninvasive biomimetic, bioinspired, and bioengineered drug delivery system (DDS). Noninvasive DDS is an ever-growing field critical for the applicability of drugs. It offers noninvasive administration routes with improved controlled, targeted, and triggered drug delivery. Noninvasive DDS employ many approaches and strategies, such as, nano-and microparticles, lipid-based systems, sonophoresis, electrophoresis and iontophoresis, penetration enhancers, microneedles, and gels. The last decade seen a surge in research papers employing the paradigms of biomimicry, bioinspiration, and bioengineering. However, since the use of these terms in noninvasive DDS field is often inconsistent and unclear, some generalized perspectives are provided on the possible usage of these terms in future publications. Additionally, a critical discussion on the novelty and origins of these paradigms is provided. The advantages and disadvantages of each of the noninvasive routes and their current main limitations are summarized. The main aspects of indicated fields are discussed: The unique physiology of the related tissues, the main hurdles for mass transport, the various DDS tested, and materials selection. Finally, the basic concepts and therapeutic effects of these DDS are discussed and future venues for noninvasive biomimetic, bioinspired, and bioengineered DDS research are proposed.

Biofuel is considered one of the most viable alternatives to fossil fuels derived from the dwindling petroleum resources that damage the environment. Bioethanol could be manufactured from agricultural wastes, thus providing inexpensive natural resources. Several strategies have been utilized to convert lignocellulosic hydrolysate to bioethanol with various suspended microorganisms. In this study, we alternatively propose to encapsulate these microorganisms in bioreactor setups. An immobilized cell system can provide resistance to the inhibitors present in hydrolysates, enhance productivity, facilitate the separation process, and improve microorganism recycling. Herein, we developed a continuous bioethanol production process by encapsulating three types of micro-organisms: T. reesei, S. cerevisiae, and P. stipitis. These microorganisms were encapsulated in SBP (“Small Bioreactor Platform”) capsules and tested for their viability post encapsulation, biological activity, and bioethanol production. Encapsulating microorganisms in SBP capsules provided a confined protective environment for the microorganisms, facilitated their acclimation, and ensured their long-term prosperity and activity. An additional significant benefit of utilizing SBP capsules was the simultaneous availability of saccharification and fermentation over a very long time—about 2.5–3 months—with no need to renew the cells or encapsulating matrices. Two different configurations were tested. The first one consisted of columns packed with fungal cells and specific yeast cells together. In the second configuration, the fungal cells were separated from the yeast cells into two columns in series. The presented systems achieved an efficiency of 60–70%, suggesting the long-term prosperity and uninterrupted metabolic activity of the microorganisms.